Dubai Municipality named UAE Country Winner in the 2025 International Safety Awards
The Municipality was selected from hundreds of entries across the globe, including institutions from the United Kingdom, Europe, Africa, Asia, and the Middle East. It is one of just 10 organisations worldwide to receive the coveted Country Winner title this year, reinforcing its position as a standard-bearer for occupational health and safety in the region.
Advancing Dubai's vision for global leadership
Dr Naseem Mohammed Rafee, CEO of the Environment, Health, and Safety Agency at Dubai Municipality, said: 'This achievement reflects Dubai Municipality's unwavering commitment to fostering a sustainable preventive culture and managing risk in line with international best practices. It supports our vision of making Dubai a global benchmark for liveability, with a world-class health and food safety ecosystem. The award affirms our ongoing efforts to apply occupational safety models that reflect the highest global standards.'
Integrated excellence in occupational safety
Dubai Municipality earned this global recognition through its proactive approach to health and safety management. Key strengths included the adoption of internationally recognised systems, the implementation of forward-looking policies to protect employees and reduce workplace risks, and sustained investments in safety innovation.
The Municipality also demonstrated leadership in promoting employee wellbeing, reducing incidents and injuries, and embedding a culture of safety through education, training, and the application of smart technologies. These integrated efforts contribute to a safer, healthier, and more sustainable working environment — one that reinforces Dubai's reputation as a model city for urban excellence.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arabian Business
3 hours ago
- Arabian Business
Qatar takes action against spas over indecent ads violating public morals
Qatar has taken strong legal action against spas for violating decency laws in the country. The Ministry of Commerce and Industry (MOCI) has taken legal action against four wellness spa establishments after discovering advertisements that violated public decency laws and religious values. The ministry confirmed that the offending businesses had published promotional content containing images and messaging deemed inappropriate, breaching Article No. 2 of Law No. 8 of 2008 on consumer protection. Qatar spas face legal action All four facilities have been issued official violation notices and referred to relevant authorities for further investigation and possible legal proceedings. In a statement released Wednesday, MOCI reiterated that such advertisements 'run roughshod over the religious values, customs, and traditions upheld by the nation.' The ministry emphasised its ongoing commitment to fostering a responsible commercial environment and protecting the community from indecent marketing practices. MOCI confirmed that its inspection teams will continue their surveillance efforts to ensure full compliance with advertising regulations and business conduct codes. The ministry also urged the public to report any violations or unethical practices through its call centre (16001) or official social media platforms.
Khaleej Times
3 hours ago
- Khaleej Times
Burjeel net profit surges 128.9% in the second quarter
Burjeel Holdings delivered strong top-line growth of 18.7 per cent to Dh1,403 million in Q2'25, driven by a 12.1 per cent increase in patient footfall, higher patient yield, and the continued ramp-up of newly launched facilities across the network, the super-specialty healthcare services provider announced on Thursday. Net profit surged 128.9 per cent to Dh148 million in Q2'25, reflecting margin expansion, enhanced operating leverage, and asset optimisation. In H1'25, net profit rose 10.6 per cent to Dh187 million. Ebitda rose 59.4 per cent to Dh306 million in Q2'25, fuelled by strong revenue growth, enhanced physician productivity, and better performance across recently ramped-up assets. This includes Dh72 million in gains from lease liability derecognition following the Dubai Medeor Hospital acquisition. The Ebitda margin expanded 5.6 p.p. to 21.8 per cent. In H1'25, Ebitda increased 14.2 per cent to Dh487 million, with a margin of 18.2 per cent. Revenue in H1'25 rose 12.2 per cent to Dh2,677 million, with total patient visits reaching 3.4 million. Oncology remained a core growth driver, with revenue rising 36.7 per cent in Q2'25 and 38.1 per cent in H1'25, underpinned by oncology network expansion and improved conversion in surgical and advanced therapies. Other specialties also recorded solid gains in H1'25, including urology (+18 per cent), emergency medicine (+17 per cent), cardiology (+16 per cent), and gastroenterology (+13 per cent). John Sunil, CEO of Burjeel Holdings, was optimistic about maintaining strong momentum through the second half. 'We continue to target mid-teens revenue growth for the year, supported by the ramp-up of new assets and strategic expansion in both the UAE and Saudi Arabia,' he said. A key focus is making sure that Burjeel's new centres and services are launched smoothly and begin contributing at full potential. 'Major investments in specialised care, technology, and new geographies do not translate into financial returns overnight. But the strategy we have been executing is absolutely the right one, and this quarter's results are a clear example of how our growth strategy and investments in complex care are beginning to yield measurable financial results,' Sunil said. Inpatient footfall rose 17.7 per cent in Q2'25, reflecting strong demand across key specialties and a ramp-up in elective surgeries post-Ramadan. Outpatient footfall grew 12.0 per cent in Q2'25, accelerating from 5.2 per cent in Q1, driven by primary care and physiotherapy centers, along with robust demand in oncology, pediatrics, ophthalmology, and family medicine. Utilisation improved to 68 per cent, up from 65 per cent in Q1'25, enabled by optimised hiring and scaling of clinical teams. The Hospitals segment continued to drive group performance, contributing 89 per cent of total revenue in Q2'25. Revenue grew 17.3 per cent to Dh1,245 million, supported by strong growth in patient volumes and sustained demand for complex care services. Segment Ebitda rose by 40.6 per cent, led by strong performance across key hospitals. Operating cash flow increased 8.1 per cent YoY in H1'25, driven by improved operational performance and disciplined working capital management. Maintenance capex remained in line with guidance, while growth capex totalled Dh403 million, driven by strategic M&A activities and ongoing network expansion. Free cash flow conversion improved to 54 per cent in H1'25. In May 2025, the Group declared a full-year dividend of Dh170 million for FY2024, representing 47 per cent of net profit. Cost control was a key contributor to the company's performance. 'Even with 143 new physicians onboarded over the past year, we were able to optimise personnel costs through better workforce planning and clinical scheduling. We also brought overheads down by 7 per cent quarter-on-quarter and over 13 per cent compared to Q4, by normalising spend and embedding stronger cost discipline across the group. These efforts, alongside strong top-line growth, drove a significant improvement in margins,' Sunil said. The Trust Fertility Center, now the largest in the UAE, broke even within six months and has served over 1,800 unique patients with outcomes well above global benchmarks. 'It plays a key role in our women's health platform and aligns with the UAE's national fertility strategy. Looking ahead, we're replicating this model in Al Ain and Dubai, while continuing to invest in precision medicine, AI-enabled care, and complex specialties,' Sunil said.
Arabian Business
4 hours ago
- Arabian Business
Burjeel bounces back with strong Q2 numbers after March lows
With a rise in its number of inpatient and outpatient footfall, higher patient yield, and the continued ramp-up of newly launched facilities across the network, Burjeel Holdings announced an impressive 128.9 per cent jump in net profit to AED 148 million (US$40.3 million) in the second quarter of 2025. Net profit for the first six months rose 10.6 per cent to AED 187 million (US$50.9 million). The rise in net profit for Q2 was also due to a decline in footfall for the month of March, which was attributed by the company to the Holy Month of Ramadan. Those numbers were overwhelmingly reversed in the second quarter of the year, as inpatient footfall rose 17.7 per cent, and outpatient footfall grew 12 per cent. Revenue grew 18.7 per cent to AED 1,403 million (US$382 million) in Q2'25, while revenue for the first six months rose 12.2 per cent to AED 2,677 million (US$728.9 million). Total patient visits reached 3.4 million. The Group performed 22,930 surgeries, up 18.7 per cent. Bed occupancy improved to 69 per cent, up from 65 per cent a year ago. Inpatient volumes rose 14.6 per cent over the first half. The outpatient footfall was driven by primary care and physiotherapy centers, along with strong demand in oncology, pediatrics, ophthalmology, and family medicine. Utilisation improved to 68 per cent, up from 65 per cent in Q1'25. Oncology remained a core growth driver, with revenue rising 36.7 per cent in Q2'25 and 38.1 per cent in H1'25. This was made possible by oncology network expansion and improved conversion in surgical and advanced therapies. Other specialties also recorded good gains in H1'25, including urology (+18 per cent), emergency medicine (+17 per cent) and cardiology (+16 per cent). John Sunil, Chief Executive Officer of Burjeel Holdings, commented: 'The second quarter delivered exceptionally strong results, with 19 per cent revenue growth driven by a 12 per cent increase in patient footfall and improved yield. EBITDA rose by 59 per cent, accompanied by a margin uplift to 22 per cent. This robust performance significantly strengthened the first-half outcome, underscoring Burjeel Holdings' resilience and long-term sustainable growth. 'These results reflect tangible progress in key operational areas such as physician manpower optimisation, formulary management, and cost control, while our strategic focus on super-specialty care is beginning to yield measurable benefits, enhancing both revenue and profitability. We continue to invest in high-value services and next-generation care facilities to support long-term momentum. 'We also advanced key strategic priorities, reinforcing leadership in complex care across oncology, transplants, fertility, mental health, and diagnostics. Our oncology platform is now the UAE's largest private network, featuring new cancer clinics and cell and gene therapy capabilities.' EBITDA rose 59.4 per cent to AED 306 million (US$83.3 million) in Q2'25, fueled by strong revenue growth, enhanced physician productivity, and better performance across recently ramped-up assets. This includes AED 72 million (US$19.6 million) in gains from lease liability derecognition following the Dubai Medeor Hospital acquisition. The EBITDA margin expanded 5.6 points to 21.8 per cent. In H1'25, EBITDA increased 14.2 per cent to AED 487 million (US$132.6 million). 'Burjeel Holdings is uniquely positioned to capture significant opportunities across the region, supported by rising demand for complex care and a growing population. Our focus remains on converting recent investments into sustained expansion and margin improvement, while maintaining disciplined financial management to support long-term shareholder value,' Sunil added. 'Net profit growth of 129 per cent in the reporting quarter reinforces this trajectory and strengthens the foundation for consistent shareholder returns.'
